Abstract:The hygiene hypothesis has been popularized as an explanation for the rapid increase in allergic disease observed over the past 50 years. Subsequent epidemiological studies have described the protective effects that in utero and early life exposures to an environment high in microbial diversity have in conferring protective benefits against the development of allergic diseases. The rapid advancement in next generation sequencing technology has allowed for analysis of the diverse nature of microbial communities present in the barrier organs and a determination of their role in the induction of allergic disease. Here, we discuss the recent literature describing how colonization of barrier organs during early life by the microbiota influences the development of the adaptive immune system. In parallel, mechanistic studies have delivered insight into the pathogenesis of disease, by demonstrating the comparative effects of protective T regulatory (Treg) cells, with inflammatory T helper 2 (Th2) cells in the development of immune tolerance or induction of an allergic response. More recently, a significant advancement in our understanding into how interactions between the adaptive immune system and microbially derived factors play a central role in the development of allergic disease has emerged. Providing a deeper understanding of the symbiotic relationship between our microbiome and immune system, which explains key observations made by the hygiene hypothesis. By studying how perturbations that drive dysbiosis of the microbiome can cause allergic disease, we stand to benefit by delineating the protective versus pathogenic aspects of human interactions with our microbial companions, allowing us to better harness the use of microbial agents in the design of novel prophylactic and therapeutic strategies.

Early-life interactions between the microbiota and immune system: impact on immune system development and atopic disease

Priming for Life: Early Life Nutrition and the Microbiota-Gut-Brain Axis

The Role of Microbiota in Infant Health: from Early Life to Adulthood

Early life microbiome influences on development of the mucosal innate immune system

Immune-microbe interactions early in life: A determinant of health and disease long term

Early-Life Nutrition and Gut Immune Development

Development of systemic and mucosal immune responses against gut microbiota in early life and implications for the onset of allergies

Mechanisms of microbe-mediated immune development in the context of antibiotics and asthma

Impact of Early Gut Microbiota on Immune and Metabolic Development and Function

Microbial Dysbiosis Tunes the Immune Response Towards Allergic Disease Outcomes

The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases

Maternal and early life exposures and their potential to influence development of the microbiome

Asthma and the microbiome: defining the critical window in early life

Environmental influences on childhood asthma—The effect of diet and microbiome on asthma

Early gut colonization by Bifidobacterium breve and B. catenulatum differentially modulates eczema risk in children at high risk of developing allergic disease

The Development of Early Life Microbiota in Human Health and Disease

Effects of early postnatal life nutritional interventions on immune-microbiome interactions in the gastrointestinal tract and implications for brain development and function

Infant gut microbiota and the hygiene hypothesis of allergic disease: impact of household pets and siblings on microbiota composition and diversity

Microbiome Composition and Its Impact on the Development of Allergic Diseases

Delayed gut microbiota maturation in the first year of life is a hallmark of pediatric allergic disease

Early life gut microbiota: Consequences for health and opportunities for prevention